Navigation Links
Damon Runyon Cancer Research Foundation awards $2.7M to 7 top young clinical investigators
Date:6/30/2009

ing donor T immune cell activity to prevent acute graft-versus-host disease (GvHD) in cancer patients treated with bone marrow transplantation. His hypothesis is that regulatory T cells (Treg) can be used to suppress GvHD while preserving beneficial anti-tumor immunity. This work could have significant translational implications by reducing GvHD-associated mortality, thus improving the success of bone marrow transplantation in treatment of hematologic cancers such as leukemia and lymphoma.

Dr. Nguyen works under the mentorship of Thomas F. Gajewski, MD, PhD, at The University of Chicago, Chicago, Illinois.

2009 Clinical Investigator Continuation Grants

Renier J. Brentjens, MD, PhD [Lilly Investigator]

Dr. Brentjens is leading an innovative Phase I trial using patients' own genetically modified immune T cells to treat chronic lymphocytic leukemia (CLL). His Continuation Grant will be used to complete this trial, while also initiating a related clinical trial to treat pediatric patients with acute lymphocytic leukemia (ALL). These are patients for whom all other treatment options have been exhausted.

Dr. Brentjens works under the mentorship of Michel Sadelain, MD, PhD, at Memorial Sloan-Kettering Cancer Center, New York, New York.

Patrick A. Brown, MD [Lilly Investigator]

Dr. Brown is leading two national Phase I/II clinical trials focused on the first use of a small molecule inhibitor drug for the treatment of two types of pediatric leukemias, acute lymphocytic leukemia (ALL) and acute myelogenous leukemia (AML). He is also developing a new test to predict patient response to this drug. The Continuation Grant will be used to complete these trials, which may lead to improved outcome for children with this disease.

Dr. Brown works under the mentorship of Donald Small, MD, PhD, at The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Andrea L. Cox,
'/>"/>

Contact: Yung S. Lie, Ph.D.
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young scientists
2. NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck
3. Reminder: Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
4. Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
5. The 2009 Damon Runyon-Rachleff Innovation Award Granted for Pioneering Ideas for Early Detection of Ovarian and Lung Cancers, Bone Marrow Transplant Safety, and Discovery of New Genetic Markers for Cancer
6. Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators
7. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 14 top young investigators
8. Damons Grill Completes Move to Trans Fat-Free Menu
9. Bladder Cancer No Longer a Death Sentence
10. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
11. AACE Response to Insulin Glargine Cancer Risk Articles in Diabetologia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 30, 2015 Boston Scientific Corp. ... punitive and compensatory damages to a transvaginal mesh ... complications following implantation of the company’s Pinnacle and ... on May 28th in Delaware Superior Court, the ... after the jury found that the implants were ...
(Date:5/30/2015)... 2015 Nicole Blodgett, Vice President ... Associate (DIA) designation to further her expertise in ... designed for insurance advisors, health care professionals, and ... and expertise associated with the risk and the ... is only the latest accomplishment in Nicole's journey ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Wixom, Michigan: Proof. Pest ... services, has added a new twist to its robust line ... organic services are used for general pest management. ... Allan Draper, proof.’s Wixom Branch Manager. “The average person cringes ... pride in dealing with problems that most people don’t even ...
(Date:5/30/2015)... This year the National Lung Health Education ... one of the most diverse perspectives with speakers and ... diagnose, treat and manage patients with COPD. , "The ... is Interaction with Multidisciplinary Healthcare Professionals who represent various ... with COPD," said Brian W. Carlin, MD, FCCP, FAARC, ...
(Date:5/30/2015)... 30, 2015 The IRS released an ... announcing that, “criminals used taxpayer-specific data acquired from non-IRS ... 100,000 tax accounts through IRS’ “Get Transcript” application. This ... street address.” , “You don’t even have to ... think it was only a matter of time, especially ...
Breaking Medicine News(10 mins):Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 3Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 4Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:Proof. Pest Control-Now Offering 100% Organic Pest Control in Southeast Michigan 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5
... /PRNewswire-FirstCall/ - CRH Medical Corporation announced today that through ... has been adopted by more than 90% of the ... 2008. The Company believes this provides clear evidence of ... of the consistency of its training methodology. The sharing ...
... A new survey from global market research firm Synovate shows that less ... six months. Of those, only 10% received it at a pharmacy and ... ... (PRWEB) February 24, 2009 -- According to a new survey by leading ...
... Together Leading Cardiovascular ExpertsLAS VEGAS, Feb. 24 ... award-winning company engaged in pioneering highly advanced ... the Company will be showcasing its compelling ... communications products at CardioCareLive, an online-only conference ...
... health plans to adopt the same payment rules as ... Business Group on Health (MBGH) released the results of ... on their knowledge and intentions to improve the safety ... for "never events" - serious and costly preventable hospital ...
... Pioneer in Bid to Raise $1.5 MillionHOUSTON , Feb. 24 ... reach its goal of raising $1.5 million through the ... Heart Association,s Go Red For Women movement. Heart disease is ... United States, with nearly 2,400 Americans dying of the disease ...
... after,TM sessions , , TUESDAY, Feb. 24 (HealthDay News) ... stress and improve their ability to learn, suggests ... meditation (TM) on stress reactivity and brain functioning. ... Washington, D.C., area, underwent physiological and psychological tests ...
Cached Medicine News:Health News:CRH provides Partnership Program update 2Health News:New survey: Flu Shot Still not Catching on, Especially at Retail Clinics 2Health News:Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference 2Health News:Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference 3Health News:Employers Support Non-Payment for Hospital-Acquired Infections 2Health News:Employers Support Non-Payment for Hospital-Acquired Infections 3Health News:Photos: Jiffy Lube(R) Halfway Home in Drive to Fight Heart Disease with Maintenance Partners for Life Campaign 2Health News:Photos: Jiffy Lube(R) Halfway Home in Drive to Fight Heart Disease with Maintenance Partners for Life Campaign 3Health News:Photos: Jiffy Lube(R) Halfway Home in Drive to Fight Heart Disease with Maintenance Partners for Life Campaign 4Health News:Photos: Jiffy Lube(R) Halfway Home in Drive to Fight Heart Disease with Maintenance Partners for Life Campaign 5Health News:Meditation May Boost College Students' Learning 2
(Date:5/29/2015)... and BOSTON , May 29, 2015 ... development, custom automation, and contract manufacturing, and Vaxxas ... needle-free drug delivery technology, have been named winners of ... Nanopatch Jet Coating Instrument , an advanced technology ... product development.  The award was announced last evening at ...
(Date:5/29/2015)... May 29, 2015 /CNW/ - Covalon Technologies Ltd. (the ... technologies company, is delighted to announce its financial ... 2015, which includes revenue for three months of ... $264,340. Revenue from advanced wound care product sales for ... increased 24% to $1,742,672 compared to $1,400,065 for ...
(Date:5/29/2015)... VANCOUVER, British Columbia and ... DelMar Pharmaceuticals, Inc. (OTCQX: ... focused on developing and commercializing proven cancer therapies ... data at the American Association of Cancer ... on the potential for its lead product ...
Breaking Medicine Technology:Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5
... U.S. Food and Drug Administration (FDA) has accepted for ... of Keppra XR(TM) (levetiracetam) in the, adjunctive ... ATLANTA, Jan. 16 UCB announced today that ... XR(TM) (levetiracetam) extended-,release tablets in the adjunctive treatment of ...
... rate from,cancer now is lower in older adolescents and ... because of a lack of access to clinical trials,nationally ... by pediatric,oncologists at Children,s Hospital of Pittsburgh of UPMC., ... with cancer have,improved dramatically over the last 30 years, ...
Cached Medicine Technology:Keppra XR(TM) Extended-Release Tablets Filed with the FDA 2Keppra XR(TM) Extended-Release Tablets Filed with the FDA 3Keppra XR(TM) Extended-Release Tablets Filed with the FDA 4Children's Hospital Cancer Study Finds Adolescents and Young Adults Don't Get Same Access to Cutting-Edge Treatment as Younger Patients 2Children's Hospital Cancer Study Finds Adolescents and Young Adults Don't Get Same Access to Cutting-Edge Treatment as Younger Patients 3
... Timesh 1.6 Titanium Cranial Fixation Systems ... benefits specifically requested by surgeons and ... cranioplasty implants may be either shaped ... procedure warrants, a pre-measured, cut, bent ...
... LeibingerTitanium Microplus System is a ... skeletal fixation armamentarium. It may ... vault, nasal, zygomatic and orbital ... especially where increased strength over ...
... Sofwire Cable System, designed ... including sublaminar interspinous fixation, ... surgery, sternotomy closure. Consists ... a complete set of ...
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%....
Medicine Products: